The Early Clinical Response of TNF-Alpha Blockers Is a Predictor of Metrology Outcome in Ankylosing Spondylitis.

被引:0
|
作者
Nam, Eon Jeong [1 ]
Eun, Jung Soo [1 ]
Kim, Na Ri [1 ]
Kang, Jong Wan [1 ]
Im, Churl Hyun [1 ]
Kang, Young Mo [1 ]
机构
[1] Kyungpook Natl Univ Sch Med, Taegu, South Korea
来源
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2230
引用
收藏
页码:S944 / S945
页数:2
相关论文
共 50 条
  • [31] POLYMORPHISM OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AT POSITION -308 IN RELATION TO ANKYLOSING-SPONDYLITIS
    VERJANS, GMGM
    BRINKMAN, BMN
    VANDOORNIK, CEM
    KIJLSTRA, A
    VERWEIJ, CL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (01): : 45 - 47
  • [32] SHORT-TERM RESPONSE PREDICTS LONG-TERM OUTCOME AND DISCONTINUATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TNF BLOCKERS
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 617 - 617
  • [33] Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers
    Nam, Eon Jeong
    Lee, Won Kee
    MEDICINE, 2020, 99 (41) : E22668
  • [34] TNF-ALPHA INHIBITION - IMPROVEMENT IN CLINICAL OUTCOME OF ISHAEMIC STROKE
    Chatterjee, D.
    Wijenayake, I.
    Rangasamy, R.
    Nevajda, B.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 695 - 695
  • [35] TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients
    Miranda-Filloy, J. A.
    Llorca, J.
    Carnero-Lopez, B.
    Gonzalez-Juanatey, C.
    Blanco, R.
    Gonzalez-Gay, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (06) : 850 - 855
  • [36] DETERMINANTS OF 12-MONTHS PERSISTENCE IN ANKYLOSING SPONDYLITIS PATIENTS INITIATING SUBCUTANEOUS TNF-ALPHA INHIBITORS
    Fautrel, B.
    Belhassen, M.
    Hudry, C.
    Woronoff, M. -C.
    Gouyette, N.
    Clement, A.
    Van Ganse, E.
    Tubach, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 754 - 755
  • [37] TRANSGENIC MICE EXPRESSING A TRUNCATED TNF-ALPHA GENE MANIFEST AN ARTHRITIS RESEMBLING ANKYLOSING-SPONDYLITIS
    BRAHN, E
    CREW, MD
    EFFROS, RB
    WALFORD, RL
    ZELLER, E
    CHEROUTRE, H
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 480 - 480
  • [38] Anti-TNF-alpha therapy causes upregulation of HLA-B27 expression in patients with ankylosing spondylitis.
    Wittwer, H
    Gruber, R
    Landauer, N
    Koroknay, A
    Schattenkirchner, M
    Kellner, H
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90
  • [39] TNF-alpha and IL-17 cytokine levels in Brazilian patients with ankylosing spondylitis after anti-TNF therapy
    Lara-Armi, Fernanda Formaggi
    Visentainer, Jeane Eliete Laguila
    Braga, Matheus
    Zacarias, Joana Maira Valentini
    Rocha-Loures, Marco Antonio
    Neves, Janisleya Silva Ferreira
    Moliterno, Ricardo Alberto
    Sell, Ana Maria
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59
  • [40] Two year follow up results of a controlled trial of the anti-TNF alpha antibody infliximab in active ankylosing spondylitis.
    Brandt, J
    Listing, J
    Alten, R
    Bumester, G
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S172 - S173